Abstract
Honey has been shown to contain glucose oxidase, which produces gluconic acid and hydrogen peroxide from glucose. Dilution of honey results in a significant increase in the activity of this molecule. Inhibine, an antibacterial substance previously described in honey, has been identified as hydrogen peroxide, which is manufactured at inhibine assay by the natural glucose oxidase in honey. Inhibine levels have been shown to be directly associated with hydrogen peroxide production.
Keywords: Antibacterial, antimicrobial, bee products, honey, inhibine, royal jelly.
Anti-Infective Agents
Title:Honey: The Natural ‟Inhibine”
Volume: 13 Issue: 1
Author(s): Rezzan Aliyazicioglu and Laid Boukraa
Affiliation:
Keywords: Antibacterial, antimicrobial, bee products, honey, inhibine, royal jelly.
Abstract: Honey has been shown to contain glucose oxidase, which produces gluconic acid and hydrogen peroxide from glucose. Dilution of honey results in a significant increase in the activity of this molecule. Inhibine, an antibacterial substance previously described in honey, has been identified as hydrogen peroxide, which is manufactured at inhibine assay by the natural glucose oxidase in honey. Inhibine levels have been shown to be directly associated with hydrogen peroxide production.
Export Options
About this article
Cite this article as:
Aliyazicioglu Rezzan and Boukraa Laid, Honey: The Natural ‟Inhibine”, Anti-Infective Agents 2015; 13(1) . https://dx.doi.org/10.2174/2211352513666150318234101
DOI https://dx.doi.org/10.2174/2211352513666150318234101 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Role of Viruses in Neurodegenerative and Neurobehavioral Diseases
CNS & Neurological Disorders - Drug Targets Docking Studies for Multi-Target Drugs
Current Drug Targets Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases
CNS & Neurological Disorders - Drug Targets Calcium Antagonists: A Ready Prescription for Treating Infectious Diseases?
Current Topics in Medicinal Chemistry The Clinical and Immunological Features of Patients with Primary Antibody Deficiencies
Endocrine, Metabolic & Immune Disorders - Drug Targets New Target Therapies for Brain Metastases from Breast Cancer
Current Cancer Drug Targets Evaluation of Vancoplus Versus Ceftriaxone Against Cephalosporin Resistance MRSA Strain in Experimental Meningitis Model
Cardiovascular & Hematological Disorders-Drug Targets Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation
Current Pharmaceutical Design Role of Pituitary Adenylate Cyclase-Activating Polypeptide in Nociception and Migraine
CNS & Neurological Disorders - Drug Targets Selection and Evaluation of the Pediatric Epilepsy Surgical Candidates
Current Pediatric Reviews Nutritional Requirements for Maternal and Newborn Health
Current Women`s Health Reviews Role of EGFR Inhibitors in the Treatment of Central Nervous System Metastases from Non-Small Cell Lung Cancer
Current Cancer Drug Targets Synthesis, Molecular Docking and In Vitro Antimicrobial Studies of New Hexahydroindazole Derivatives of Curcumin
Letters in Drug Design & Discovery The Multimodal Treatment of Acromegaly: Current Status and Future Perspectives
Endocrine, Metabolic & Immune Disorders - Drug Targets Mitochondria: The Common Upstream Driver of Amyloid-β and Tau Pathology in Alzheimers Disease
Current Alzheimer Research Mechanisms of Drug Hypersensitivity Reactions and the Skin
Recent Patents on Inflammation & Allergy Drug Discovery Cosignaling Molecules Around LIGHT-HVEM-BTLA: From Immune Activation to Therapeutic Targeting
Current Molecular Medicine The Quantitative Structure Activity Relationships for Predicting HIV Protease Inhibition by Substituted Fullerenes
Letters in Drug Design & Discovery Biomedical Application of Polymers: A Case Study of Non-CNS Drugs Becoming CNS Acting Drugs
Central Nervous System Agents in Medicinal Chemistry Substance P in Rheumatic Diseases
Current Rheumatology Reviews